An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression-Reference-Cited by-同舟云学术

An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression

Published:2020-09-30 Issue:12 Volume:8 Page:1568-1582
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Sainson Richard C.A.^ORCID,Thotakura Anil K.,Kosmac Miha^ORCID,Borhis Gwenoline,Parveen Nahida,Kimber Rachael,Carvalho Joana,Henderson Simon J.,Pryke Kerstin L.,Okell Tracey,O'Leary Siobhan,Ball Stuart,Van Krinks Cassie,Gamand Lauriane,Taggart Emma^ORCID,Pring Eleanor J.^ORCID,Ali Hanif,Craig Hannah,Wong Vivian W.Y.,Liang Qi,Rowlands Robert J.,Lecointre Morgane,Campbell Jamie,Kirby Ian,Melvin David,Germaschewski Volker,Oelmann Elisabeth,Quaratino Sonia,McCourt Matthew

Funder

Kymab Ltd

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?;Frontiers in Immunology;2024-05-30

2. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22

3. Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy;Journal of Translational Medicine;2024-03-07

4. Small molecule agents for triple negative breast cancer: Current status and future prospects;Translational Oncology;2024-03

5. Novel targets for immune-checkpoint inhibition in cancer;Cancer Treatment Reviews;2023-11